Suxiang Technology Receives CSRC Feedback on NASDAQ IPO: Required to Verify Equity Structure Compliance, Operating Entities, and Issuance Plan

Deep News
2025/10/13

Recently, Suxiang (Cayman) received feedback from the China Securities Regulatory Commission (CSRC) regarding its overseas listing filing. The specific feedback is as follows, requesting the company to provide supplementary explanations on the following matters, with lawyers required to conduct verification and issue clear legal opinions:

1. Please explain: (1) The compliance of the equity control structure establishment, including but not limited to the specific circumstances of relevant entities involved in the construction and round-trip investment fulfilling regulatory procedures for foreign exchange management, overseas investment, foreign investment, and tax declaration, and whether they comply with the "Provisions on the Merger and Acquisition of Domestic Enterprises by Foreign Investors"; (2) The similarities and differences between the issuer's common shares and preferred shares, whether there are special rights arrangements and their impact on company operations and control.

2. Please explain: (1) The standard basis for determining domestic main operating entities; (2) Regarding the situation where domestic operating entities have unpaid registered capital, please provide supplementary explanations on the reasons and compliance; (3) In conjunction with franchise contracts, further explain the franchise business model and compliance situation; (4) The status of websites, apps, mini-programs developed and operated by your company, the scale of user information collection and storage, data collection and usage, whether there are circumstances of providing information to third parties, and arrangements or measures for protecting personal information and ensuring data security before and after listing.

3. Please explain the determination basis and reasonableness of the number of shares issued and the amount of funds raised in this offering, and provide supplementary explanations on the valuation levels of similar companies in domestic and overseas markets, roadshow and bookbuilding situations.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10